NCT06585462 - Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 9, 2024

Primary Completion Date

July 22, 2026

Study Completion Date

July 22, 2026

Conditions

Cardiometabolic Disease

Interventions

DRUG

AMG 513

AMG 513 will be administered by SC or IV injection.

DRUG

Placebo

Placebo will be administered by SC or IV injection.

DRUG

AMG 513

AMG 513 will be administered by SC injection.

DRUG

Placebo

Placebo will be administered by SC injection.

Trial Locations (5)

RECRUITING

Clinical Pharmacology of Miami, LLC, Miami

RECRUITING

Translational Clinical Research LLC, Aventura

RECRUITING

Orange County Research Center, Lake Forest

RECRUITING

Anaheim Clinical Trials, Anaheim

RECRUITING

Fomat Medical Research, Oxnard